RxDoctor Payments Data

Luz Anaya

Adult Health · Paterson, NJNPI 1366209785

Payments from drug & device makers

$856in general payments, 2019–2025

Across 24 payments — averaging $35.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Madrigal Pharmaceuticals$248
  • Bayer$123
  • AstraZeneca$119
  • Corcept Therapeutics$58
  • Amgen$54
  • Novo Nordisk$49
  • plus $205 from 9 others

What the payments were for

  • Food & beverage$856100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$856 in reported general payments places this provider in the 65th percentile of 1,135 adult health providers in New Jersey.

See all adult health providers in New Jersey

Medicare billing

Part B allowed, 2024
$4,848
Medicare patients
40
Services billed
99

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanumetSitagliptin Phos/Metformin Hcl25$15,062
JanuviaSitagliptin Phosphate15$10,437
LinzessLinaclotide11$7,965
FarxigaDapagliflozin Propanediol11$7,313
Albuterol Sulfate HfaAlbuterol Sulfate43$1,012
Diclofenac Sodium46$1,008
Atorvastatin Calcium75$783
Omeprazole50$481
Fluticasone Propionate43$440
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide19$322
Tamsulosin Hcl25$282
Losartan Potassium39$275
Metformin Hcl50$269
Rosuvastatin Calcium18$265
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst11$194

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$18$7,96511 claims
AstraZenecaFarxiga$119$7,31311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,135 adult health providers in New Jersey.

Other adult health in Paterson

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →